Versant Venture Capital VI, L.P. 13D and 13G filings for Oyster Point Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-13 4:09 pm Sale | 2023-01-03 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 0 0.000% | -2,236,888 (Position Closed) | Filing |
| 2022-01-13 4:34 pm Unchanged | 2022-01-05 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 2,236,888 8.500% | 0 (Unchanged) | Filing |
| 2021-10-27 4:32 pm Unchanged | 2021-10-18 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 2,236,888 8.600% | 0 (Unchanged) | Filing |
| 2021-05-24 4:27 pm Unchanged | 2021-05-12 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 2,236,888 8.600% | 0 (Unchanged) | Filing |
| 2021-04-05 4:33 pm Unchanged | 2021-03-26 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 2,236,888 8.600% | 0 (Unchanged) | Filing |
| 2021-03-01 5:16 pm Sale | 2021-02-17 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 2,236,888 8.600% | -325,000 (-12.69%) | Filing |